Order results by:
| Issue | Title | |
| Vol 14, No 2 (2018) | EFFECTS OF SACUBITRIL/VALSARTAN ON THE ARTERIAL STIFFNESS AND LEFT VENTRICULAR-ARTERIAL COUPLING IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION | Abstract similar documents |
| Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, Е. E. Shkolnikova, O. I. Lukina | ||
| "... /ml/m2; p=0.005) and Ea/Ees ratio (from 2.26Ѓ}0.77 to 1.68Ѓ}0.32, p=0.05) was found after 12 months ..." | ||
| Vol 13, No 3 (2017) | EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS | Abstract similar documents |
| Zh. D. Kobalava, S. V. Villevalde, I. A. Meray, O. I. Lukina | ||
| "... ; the maximum effect was achieved 2-4 hours after taking the medication (mean value 2.08, p=0.005). Sacubitril ..." | ||
| Vol 17, No 3 (2021) | Chronic Heart Failure in Patients with Arterial Hypertension Associated with Obstructive Sleep Apnea Syndrome: Possible Options to Pathogenetic Therapy | Abstract similar documents |
| A. V. Yakovlev, S. N. Shilov, E. N. Berezikova, N. F. Yakovleva, A. T. Teplyakov, E. V. Grakova, K. V. Kopeva, I. A. Efremov | ||
| "... пациенты (n=50), получавшие ОМТ с АРНИ (валсартан/сакубитрил), в группу 2 (n=86) – ОМТ с ингибитором АПФ ..." | ||
| Vol 14, No 2 (2018) | PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS | Abstract similar documents |
| S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov | ||
| "... проблему. Клинические исследования показали высокую эффективность препарата сакубитрил/валсартан в терапии ..." | ||
| Vol 18, No 6 (2022) | The Effect of Angiotensin Receptor and Neprilysin Inhibitors on Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction and Functional Mitral Regurgitation | Abstract similar documents |
| A. S. Ryazanov, E. V. Shikh, O. V. Kechina, M. V. Makarovskaya, A. A. Kudryavtsev | ||
| "... class III to II increased in the sacubitril/valsartan group (p<0.05). Also, in this group, the effective ..." | ||
| Vol 6, No 2 (2010) | VALSARTAN IN EVERYDAY CLINICAL PRACTICE IN RUSSIA: ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik | ||
| "... 22 to 16% and from 44 to 30% respectively (р<0,05). Significant increase in the number of patients ..." | ||
| Vol 9, No 3 (2013) | ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON SEXUAL FUNCTION OF VALSARTAN AND VALSARTAN AND HYDROCHLOROTHIAZIDE COMBINATION IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| V. I. Podzolkov, A. V. Vigdorchik | ||
| "... decreased from 44.7 to 32.8% and from 29.1% to 23.2%, respectively (р<0.05). Significant increase ..." | ||
| Vol 8, No 1 (2012) | THE COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL VALSARTAN AS A MONOTHERAPY OR IN COMBINATION WITH HYDROCHLOROTHIAZIDE AND BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREE AND METABOLIC SYNDROME | Abstract similar documents |
| S. Yu. Martsevich, Yu. V. Lukina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, V. P. Voronina, L. Yu. Drozdova | ||
| "... , respectively (p>0.05). Target BP was achieved in 23 patients (77%) in both randomized groups. Serious adverse ..." | ||
| Vol 6, No 5 (2010) | FIXED COMBINATION OF VALSARTAN AND AMLODIPINE: EFFECTS ON THE LEFT VENTRICULAR HYPERTROPHY REGRESSION, ALBUMINURIA REDUCTION AND ENDOTHELIUM FUNCTION IN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME | Abstract similar documents |
| Ye. I. Tarlovskaya, N. S. Maksimchuk, I. Ye. Sapozhnikova, S. V. Malchikova | ||
| "... . Endothelium-dependent vasodilation increased in 3.6±7.2% (р=em0.05/em) in comparison with baseline, LVH decreased ..." | ||
| Vol 7, No 5 (2011) | ECONOMIC BENEFITS OF LEFT VENTRICULAR HYPERTROPHY REGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchicova, M. V. Avksentieva, I. E. Sapozhnikova, Y. A. Balandina | ||
| "... decrease in LV mass from 205.8±50.4 to 181.9±45.1 g (pem0.05/em) was revealed. The model took into account ..." | ||
| Vol 15, No 1 (2019) | Improving the cognitive functions in the middle-aged patients with essential arterial hypertension after the treatment with amlodipine/valsartan single-pill combination | Abstract similar documents |
| O. D. Ostroumova, E. V. Borisova, A. I. Kochetkov, T. M. Ostroumova, O. V. Bondarec | ||
| "... em0.05/em) and delayed recall (from 5.9±1.8 to 8.2±1.4 words; р0.001). Conclusion. In retrospective ..." | ||
| Vol 15, No 3 (2019) | Effect of the Single-Pill Amlodipine/Valsartan Combination on Hypertrophy and Myocardial Deformation Characteristics in Middle-Aged Patients with Essential Arterial Hypertension | Abstract similar documents |
| A. I. Kochetkov, E. V. Borisova, O. D. Ostroumova, M. V. Lopukhina, G. V. Piksina | ||
| "... , there was a significantly (p=0.em005/em) increasing in this parameter at the end of the study (from -16.14±2.21% to -17.30±2 ..." | ||
| Vol 9, No 3 (2013) | ECONOMIC EVALUATION OF COMBINED THERAPY OF ARTERIAL HYPERTENSION BY MARKOV’S MODELING | Abstract similar documents |
| N. S. Maksimchuk-Kolobova, E. I. Tarlovskaya, S. V. Malchikova | ||
| "... . Significant decrease in LVM was observed in V/A group: from 225.1±71.7 to 186.3±44.5 g (pem0.05/em ..." | ||
| Vol 21, No 1 (2025) | Physicians’ knowledge of therapy that affecting the prognosis of patients with chronic heart failure | Abstract similar documents |
| N. B. Perepech, I. E. Mikhailova, A. V. Tregubov | ||
| "... ,01), SGLT2i (p 0,01), and MRA (p em0,05/em) more often than internists. Conclusion. Insufficient ..." | ||
| Vol 7, No 4 (2011) | COMBINATION OF DIRECT RENNIN INHIBITOR - ALISKIREN, ANGIOTENSIN II RECEPTOR BLOCKER - VALSARTAN, AND CALCIUM CHANNEL BLOCKER - AMLODIPINE, IN THERAPY OF HYPERTENSIVE PATIENT WITH GOUT (CASE REPORT) | Abstract similar documents |
| O. V. Dralova, M. L. Maksimov | ||
| "... безопасность, в частности комбинацию emвалсартана/em, амлодипина и алискирена. Представлен клинический случай ..." | ||
| Vol 14, No 3 (2018) | TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, A. V. Starodubova, I. V. Goloborodova, E. A. Smolyarchuk | ||
| "... . Особое внимание уделено доказательной базе эффективности emвалсартана/em и амлодипина как эталонных ..." | ||
| Vol 8, No 1 (2012) | EFFICACY OF FIXED COMBINATION OF VALSARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN COMPLEX THERAPY OF THE PATIENT OF VERY HIGH CARDIOVASCULAR RISK | Abstract similar documents |
| I. M. Sokolov, N. A. Zheleznyakova | ||
| Vol 10, No 1 (2014) | CHANGES IN THE PARAMETERS OF 24-HOUR BLOOD PRESSURE MONITORING AND ARTERIAL STIFFNESS IN PATIENTS WITH HYPERTENSION AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH VALSARTAN | Abstract similar documents |
| N. A. Karoli, G. R. Dolishnya, A. P. Rebrov | ||
| "... легких (ХОБЛ) на фоне применения блокатора рецепторов ангиотензина II emвалсартана/em. Материал и методы. В ..." | ||
| Vol 8, No 2 (2012) | PRELIMINARY RESULTS OF COMPARATIVE PHARMACOECONOMIC PROSPECTIVE STUDY OF DIFFERENT THERAPIES OF ARTERIAL HYPERTENSION | Abstract similar documents |
| E. I. Tarlovskaya, N. S. Maksimchuk, S. V. Malchikova, M. V. Avksentieva | ||
| "... получали фиксированную комбинацию emвалсартана/em и амлодипина в дозе 160/5 или 160/10 мг . Пациенты группы Л/А ..." | ||
| Vol 6, No 1 (2010) | ANTIHYPERTENSIVE EFFICACY OF VALSARTAN IN SMOKERS VERSUS NON-SMOKERS WITH ARTERIAL HYPERTENSION: THE FIRST RESULTS OF RUSSIAN MULTICENTER OPEN STUDY | Abstract similar documents |
| V. I. Podzolkov, V. A. Bulatov, A. V. Vigdorchik | ||
| "... Цель. Изучить антигипертензивную эффективность, переносимость и приверженность лечению emвалсартаном/em ..." | ||
| Vol 14, No 6 (2018) | The Situation with Valsartan – Commentary of S.A. Boytsov, Chief Cardiologist of Ministry of Health of Russia for the Central, Urals, Siberian and Far Eastern Federal Districts | Abstract PDF (Eng) similar documents |
| artilce Editorial | ||
| Vol 14, No 6 (2018) | The Impact of Valsartan/Amlodipine Single-Pill Combination on Blood Pressure and Vascular Stiffness in Patients with Grade 1-2 Essential Arterial Hypertension | Abstract PDF (Eng) similar documents |
| E. V. Borisova, A. I. Kochetkov, O. D. Ostroumova | ||
| "... Цель. Изучить влияние фиксированной комбинации (ФК) emвалсартан/em/амлодипин (В/А) на уровень ..." | ||
| Vol 20, No 5 (2024) | The effect of the M235T polymorphism of the angiotensinogen gene on the office blood pressure during therapy with angiotensin II receptor blockers | Abstract similar documents |
| E. V. Rebrova, E. V. Shikh | ||
| "... случайным образом (методом простой рандомизации) распределены в группы ирбесартана и emвалсартана/em в виде моно ..." | ||
| Vol 8, No 6 (2012) | SARTANS AND ANGIOTENSIN CONVERTING ENZYME INHIBITORS: A DUEL BETWEEN TWO LEADERS OF PHARMACOTHERAPY OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| K. A. Gyamdzhyan, M. L. Maksimov | ||
| Vol 8, No 5 (2012) | EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS | Abstract similar documents |
| O. A. Koshel'skaya, O. A. Zhuravleva, R. S. Karpov | ||
| "... .0±8.3 to 125.0±7.6/76.8±4.9 mm Hg (pem0.05/em) and average daily BP (ABPM) decreased to 120.1±10.0/71.7±6 ..." | ||
| Vol 6, No 1 (2010) | ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| E. M. Khurs, A. V. Poddubnaya | ||
| "... ангиотензину II (АРА II) emвалсартана/em на этапах сердечно-сосудистого континуума (ССК). Материал и методы ..." | ||
| Vol 14, No 2 (2018) | SINGLE AND MULTIPLE ISCHEMIC BRAIN MICROLESIONS AFTER CAROTID ARTERY STENTING | Abstract similar documents |
| E. S. Bulgakova, T. V. Tvorogova, В. A. Rudenko, O. М. Drapkina | ||
| "... =-0.278; p0.01), systolic blood pressure (SBP) level before CAS (γ=0.190; pem0.05/em) and diastolic blood ..." | ||
| Vol 18, No 5 (2022) | Pararenalfat Tissue: Rate of Pararenal Obesity and Relation with Anthropometric Indices of Obesity | Abstract similar documents |
| V. I. Podzolkov, A. E. Bragina, K. K. Osadchiy, J. N. Rodionova, D. A. Bayutina | ||
| "... .46) cm. There were correlations between PRFT thickness and glucose (r=0,64, pem0,05/em) and uric acid (r=0 ..." | ||
| Vol 18, No 5 (2022) | Hepcidin as a Regulator of Iron Metabolism and Mediator of Inflammation in Patients with Chronic Heart Failure and Anemia of Chronic Diseases of the Elderly and Senile Age | Abstract similar documents |
| N. I. Solomakhina, A. S. Lishuta, A. V. Dementieva | ||
| "... with the ferrokinetic parameter – serum iron [r(S)=0.480, pem0.05/em] were found in the control group. Normal levels ..." | ||
| Vol 6, No 4 (2010) | MODERN PHARMACOTHERAPY OF THE STABLE ANGINA: POSSIBILITIES AND PROSPECTS OF NICORANDIL IMPLEMENTATION | Abstract similar documents |
| Z. M. Sizova, E. V. Shikh, V. L. Zakharova, E. V. Smirnova | ||
| "... attacks reduced by 60% (рem0.05/em) and 47% (рem0.05/em) in 12 weeks of nicorandil and amlodipine therapy ..." | ||
| Vol 14, No 2 (2018) | CHANGE IN THE FUNCTIONAL STATE OF ERYTHROCYTES AS A COMPONENT OF MICROCIRCULATORY DISORDERS IN METABOLIC SYNDROME | Abstract similar documents |
| V. I. Podzolkov, T. V. Koroleva, A. Е. Bragina, M. G. Kudryavtseva, N. A. Druzhinina, M. V. Pisarev | ||
| "... with MS was 7.3Ѓ}1.9%. The mean EEC level in group of MS patients (1.59Ѓ}em0.05/em×107) was significantly lower ..." | ||
| Vol 7, No 6 (2011) | MITRAL ANNULAR CALCIFICATION IN ELDERLY PATIENTS. CLINICAL AND ECHOCARDIOGRAPHIC CHARACTERISTICS | Abstract similar documents |
| N. S. Chipigina, G. M. Urvacheva, N. A. Shostak, I. V. Zhitareva, I. Yu. Zhitomirskaya | ||
| "... .4±5.4 years vs 70.2±4.3 years; pem0.05/em) and had higher frequency of moderate or severe hypertension (99 ..." | ||
| Vol 8, No 3 (2012) | EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES | Abstract similar documents |
| O. A. Koshel'skaya, O. A. Zhuravleva | ||
| "... выраженной нефроангиопатии. Исследование завершили 59 пациентов. Больные группы 1 (n=41) получали emвалсартан/em ..." | ||
| Vol 14, No 5 (2018) | The Potential of the Volumetric Sphygmography for the Diagnosis of Impaired Arterial Stiffness in Patients with Uncomplicated Arterial Hypertension and Its Possibilities for Evaluation of the Antihypertensive Therapy Effectiveness | Abstract similar documents |
| E. V. Borisova, A. I. Kochetkov, O. D. Ostroumova | ||
| "... антигипертензивной терапии (ФК периндоприла аргинин/индапамид или emвалсартан/em/амлодипин) был достигнут целевой уровень ..." | ||
| Vol 7, No 5 (2011) | EFFICACY AND SAFETY OF IVABRADINE AND BISOPROLOL IN PATIENTS WITH ISCHEMIC HEART DISEASE: RESULTS OF COMPARATIVE RANDOMIZED OPEN STUDY | Abstract similar documents |
| R. D. Kurbanov, A. O. Kan, F. M. Bekmetova, A. B. Shek | ||
| "... . Results. Heart rate reduced by 16.7±4.6 (p0.em005/em) and 16.4±4.8 bpm (p0.em005/em) after 2 weeks of treatment ..." | ||
| Vol 2, No 1 (2006) | EFFECT OF ANTIHYPERTENSIVE THERAPY WITH RILMENIDINE ON COGNITIVE FUNCTION IN ELDERLY HYPERTENSIVE PATIENTS | Abstract similar documents |
| S. V. Nedogoda, U. A. Brel, T. A. Tchalyaby, E. S. Kesareva, V. A. Tcoma | ||
| "... .01) and diastolic blood pressure (DBP) by 5.5% (pem0.05/em) was observed. Therapy with rilmenidine showed decrease ..." | ||
| Vol 17, No 2 (2021) | Adherence to Medical Treatment in Elderly Patients with Coronary Artery Disease in the Settings of Primary Outpatient Care | Abstract PDF (Eng) similar documents |
| S. K. Zyryanov, S. B. Fitilev, A. V. Vozzhaev, I. I. Shkrebneva, N. N. Shindryaeva, D. A. Klyuev, L. N. Stepanyan, A. M. Lutsenko, A. T. Tsai, A. A. Danilova | ||
| "... patients. These groups were comparable in terms of sex (female 71.2 vs 68.0%; pem0.05/em) and age (median 73 ..." | ||
| Vol 9, No 6 (2013) | PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE | Abstract similar documents |
| P. V. Dolotovskaya, E. Y. Rudnichenko, N. V. Furman, O. V. Reshet'ko | ||
| "... improving STEMI prognosis - thrombolytics (21% vs 50%; pem0.05/em), statins (20% vs 53%; pem0.05/em), beta-blockers ..." | ||
| Vol 9, No 1 (2013) | ASTHENIC DISORDERS IN ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION: MANAGEMENT POTENTIAL OF MELDONIUM | Abstract similar documents |
| M. E. Statsenko, S. V. Nedogoda, S. V. Turkina, I. A. Tyshchenko, L. V. Poletaeva, V. V. Tsoma, A. A. Ledyaeva, E. V. Chumachok | ||
| "... a number of patients with general asthenia decreased on 70.5% (pem0.05/em), with physical asthenia — on 47 ..." | ||
| Vol 14, No 3 (2018) | RELATION OF DISTURBANCES IN THE ERYTHROCYTES ELECTRICAL ACTIVITY WITH DYSLIPIDEMIA IN THE METABOLIC SYNDROME | Abstract similar documents |
| V. I. Podzolkov, T. V. Koroleva, A. E. Bragina, M. G. Kudryavtseva, G. I. Bragina, M. V. Pisarev | ||
| "... , hyperglycemia – in 39%, diabetes – in 36%, dyslipidemia – in 80% of patients. The EEC in MS patients (1.59±em0.05/em ..." | ||
| Vol 14, No 1 (2018) | ASSOCIATION OF RISK FACTORS FOR NON-COMMUNICABLE DISEASES WITH HEALTH CARE RESOURCES UTILIZATION AND TEMPORARY DISABILITY ACCORDING TO DATA OF POPULATION STUDY IN RUSSIAN FEDERATION | Abstract similar documents |
| E. I. Suvorova, S. A. Shalnova, A. V. Kontsevaya, A. D. Deev, A. V. Kapustina, Yu. A. Balanova | ||
| "... increased in group with tobacco consumption (1,41; pem0,05/em) and obesity (1,32; pem0,05/em), also number ..." | ||
| Vol 11, No 5 (2015) | Changes in serum lipids in patients with rheumatoid arthritis treated with a combination of tocilizumab and methotrexate compared with methotrexate alone for 24 weeks of observation | Abstract similar documents |
| E. V. Udachkina, D. S. Novikova, T. V. Popkova, E. Yu. Panasyuk, A. S. Avdeeva, A. V. Volkov, I. G. Kirillova, E. I. Markelova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov | ||
| "... (n=19; 57.6%) compared with the group TCZ+MTX (n=7; 18%), (pem0.05/em). The lipid levels correlated ..." | ||
| Vol 18, No 5 (2022) | Insulin-like Growth Factor-1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Origin | Abstract similar documents |
| A. N. Zakirova, N. E. Zakirova, D. F. Nizamova | ||
| "... ; рem0,05/em). In patients of class III-IV CHF, correlation relationships between IGF-1 level ..." | ||
| Vol 17, No 1 (2021) | Transforming Growth Factor β1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Genesis | Abstract similar documents |
| N. E. Zakirova, A. N. Zakirova, D. F. Nizamova | ||
| "... CHF; р em0.05/em). In patients of class III-IV CHF, correlation relationships between ТФР-β1 level ..." | ||
| Vol 16, No 6 (2020) | Optimal Organ Protection and Blood Pressure Control with the Single Pill Combination Lisinopril, Amlodipine and Indapamide in Arterial Hypertension | Abstract similar documents |
| S. V. Nedogoda, T. N. Sanina, V. V. Tsoma, A. A. Ledyaeva, E. V. Chumachek, A. S. Salasyuk, D. S. Vlasov, O. I. Bychkova | ||
| "... em0,05/em). There were positive changes in hsCRP level (-13.0%, pem0.05/em) and serum uric acid (-9.0%, pem0.05/em ..." | ||
| Vol 8, No 6 (2012) | THE EFFECT OF MAGNESIUM DRUGS ON THE PHYSICAL PERFORMANCE OF YOUNG PEOPLE WITH MITRAL VALVE PROLAPSE: RESULTS OF NONCOMPARATIVE STUDY | Abstract similar documents |
| K. M. Dzeranova, A. G. Avtandilov, N. V. Vertkina | ||
| "... product elevated from 1.86±em0.05/em to 2.06±em0.05/em units (p0.001); threshold power increased - relative ..." | ||
| Vol 9, No 1 (2013) | ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION | Abstract similar documents |
| A. N. Zakirova, E. R. Abdukova, N. E. Zakirova | ||
| "... without AF (65%, 56.1%, 36.3% and 13.9%, respectively, pem0.05/em). Direct correlations between sVCAM-1 level ..." | ||
| Vol 10, No 1 (2014) | THE ROLE OF THE MATRIX METALLOPROTEINASES IN THE DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME | Abstract similar documents |
| A. N. Zakirova, E. Z. Fatkullina, N. E. Zakirova | ||
| "... .61 and 183.6±17.2 ng/ml in grade 3 obesity vs 3.5±0.3 and 291.7±22.4 ng/ml in grade 1 obesity; pem0.05/em ..." | ||
| Vol 11, No 5 (2015) | Three-year dynamics and unsolved problems of lipid-lowering therapy | Abstract similar documents |
| V. A. Sergeeva | ||
| "... . The number of patients informed on atherosclerosis aspects increased from 52% to 59% (pem0.05/em) in 3 years ..." | ||
| Vol 8, No 4 (2012) | THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| L. E. Chekuldaeva, S. V. Obuhova, A. A. Simakov, L. V. Poljaeva, E. I. Rjazanova | ||
| "... — by 61.8%, after 2 months — 72.5%, pem0.05/em) were found in the intervention group compared with the control ..." | ||
| Vol 18, No 4 (2022) | Left Atrium Involvement in Lymphoma Patients: Single Center Observational Study | Abstract similar documents |
| E. Yu. Salakheeva, I. Ya. Sokolova, O. V. Lyapidevskaya, K. A. Zhbanov, S. A. Tsatsurova, N. I. Kanevskiy, V. O. Stebakova, E. V. Privalova, I. S. Ilgisonis, Yu. N. Belenkov, A. A. Shchendrygina | ||
| "... : 57% vs 10% and 33% respectively (pem0.05/em). Lymphoma patients had a higher number of premature ..." | ||
| Vol 18, No 3 (2022) | Aromatic Amino Acids: Phenylalanine and Tyrosine in Patients with Hypertension and Coronary Artery Disease | Abstract similar documents |
| A. V. Krivova, M. V. Kozhevnikova, E. O. Korobkova, V. Yu. Zektser, E. A. Zheleznykh, А. A. Ageev, N. E. Moskaleva, A. V. Kukharenko, S. A. Appolonova, Yu. N. Belenkov | ||
| "... . A negative correlation of low-density lipoproteins (LDL) with the level of Phe (r=-0,685, pem0,05/em) and Tyr (r ..." | ||
| Vol 14, No 1 (2018) | COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 | Abstract similar documents |
| O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman | ||
| "... of identified arrhythmias and severe forms of arterial hypertension significantly (82.1 vs 77%; рem0.05/em ..." | ||
| Vol 17, No 4 (2021) | E-cigarette Smoking (Vaping) and Markers of Vascular Wall Damage in Young Subjects without Cardiovascular Disease | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, A. E. Bragina, N. A. Druzhinina, L. N. Mohammadi | ||
| "... with the smoker's index (rs=0.31, pem0.05/em), and AU (rs=0.54, pem0.05/em) and ABI (rs=-0.28, pem0.05/em) with a daily ..." | ||
| Vol 18, No 3 (2022) | Lipid profile of patients with arterial hypertension who underwent COVID-19: possibilities of drug therapy/ LEADER | Abstract similar documents |
| I. A. Zolotovskaya, V. P. Kuzmin, O. A. Rubanenko, P. R. Shatskaya, A. S. Salasyuk | ||
| "... frequent use of angiotensin II receptor blockers in group 2, pem0.05/em), lipid profile and blood pressure ..." | ||
| Vol 12, No 2 (2016) | LEFT VENTRICULAR REMODELING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH AND WITHOUT ST SEGMENT ELEVATION | Abstract similar documents |
| N. E. Zakirova, Z. A. Kazieva, A. N. Zakirova | ||
| "... contractile function (LV ejection fraction 40.2±5.49% vs. 61.4±3.91% in control; pem0.05/em), the LV dilatation ..." | ||
| Vol 13, No 3 (2017) | EFFECT OF EPINEPHRINE ADMINISTRATION ON MYOCARDIAL REMODELING IN EXPERIMENTAL STUDY | Abstract similar documents |
| V. R. Veber, S. V. Zhmailova, M. P. Rubanova, P. M. Gubskaya | ||
| "... injection of epinephrine in both theLV (3.95±0.64-vs 6.83±0.30 vol% in the control group; pem0.05/em) and RV (4 ..." | ||
| Vol 14, No 1 (2018) | THIRTY-YEAR CHANGES IN AVERAGE BLOOD LIPIDS LEVELS IN POPULATIONS OF THE RUSSIAN FEDERATION AND THE USA | Abstract PDF (Eng) similar documents |
| S. A. Shalnova, V. G. Vilkov, V. A. Metelskaya, Yu. A. Balanova, A. V. Kapustina | ||
| "... , as compared to the USA one, most age groups demonstrate a higher concentration of total cholesterol, i.e. pem0.05/em ..." | ||
| Vol 6, No 3 (2010) | EFFECT OF FLUOXETINE ON SLEEP ARCHITECTURE IN PATIENTS WITH METABOLIC SYNDROME AND OBSTRUCTIVE SLEEP APNEA SYNDROME | Abstract similar documents |
| O. V. Lyubshina, A. L. Vertkin, M. Yu. Maksimova | ||
| "... and pulseoxymetry. Results. Decrease in wake time after sleep onset (Δ33%; рem0.05/em) was found at the end ..." | ||
| Vol 7, No 5 (2011) | ARRESTING OF COMPLICATED HYPERTENSIVE CRISES IN THE PHYSICIAN’S PRACTICE: URAPIDIL VALUE AND STUDY RESULTS | Abstract similar documents |
| G. P. Arutyunov, L. G. Oganezova | ||
| "... ) in the urapidil group reduced from 210.5±13.6 to 157.8±8.3 mmHg (pem0.05/em), and diastolic BP (DBP) - from 115.7±8 ..." | ||
| Vol 9, No 4 (2013) | COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE | Abstract similar documents |
| L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky | ||
| "... elective cardioversion was 21±2 and 30.5±4.5 days for dabigatran and warfarin groups, respectively (pem0.05/em ..." | ||
| Vol 9, No 2 (2013) | PLEIOTROPIC EFFECTS OF PARATHYROIDECTOMY AND AGONIST CALCIUM-SENSITIVE RECEPTOR, CINACALCET | Abstract similar documents |
| L. V. Egshatyan, L. Ya. Rozhinskaya, N. S. Kuznetsov, M. Sh. Shamkhalova | ||
| "... and parathyroidectomy (pem0.05/em). BP reduction not requiring antihypertensive drugs dose adjustment was found in patients ..." | ||
| Vol 11, No 5 (2015) | Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders | Abstract similar documents |
| B. U. Mardanov, M. N. Mamedov, M. N. Korneeva, R. G. Oganov | ||
| "... was detected significantly more frequently (73.7% vs 49%; pem0.05/em), and a class of acute heart failure (Killip ..." | ||
| Vol 8, No 3 (2012) | COMPARATIVE EFFECTIVENESS PIPOFEZINE, TIANEPTINE AND CHLORPROTHIXENE IN PATIENTS WITH ATTENTION DEFICIT DISORDER , AND HYPERTENSION: AN OPEN NON-RANDOMIZED STUDY | Abstract similar documents |
| V. V. Glushchenko | ||
| "... of neurophysiological parameters (increase in EEG frequencies index) in groups 1 and 2 (from 0.37±em0.05/em to 0.54±0 ..." | ||
| Vol 8, No 2 (2012) | QUALITY OF LIFE AND ITS DYNAMICS IN PATIENTS WITH ATRIAL FIBRILLATION AFTER LEAVING THE INTERNATIONAL CLINICAL TRIAL | Abstract similar documents |
| E. L. Artanova, L. E. Kon'shina, I. M. Sokolov, Y. G. Shvarts | ||
| "... .0-77.0) to 52 (25.0–55.0) points (pem0.05/em) and emotional component – from 65 (55.0-70.0) to 60 (50.0–65 ..." | ||
| Vol 14, No 6 (2018) | Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation) | Abstract PDF (Eng) similar documents |
| L. A. Khaisheva, S. E. Glova, V. A. Suroedov, A. S. Samakaev, S. V. Shlyk | ||
| "... of adherence to DAT was found in patients with AMI compared with patients with UA (pem0.05/em). When analyzing ..." | ||
| Vol 4, No 4 (2008) | EFFICACY AND SAFETY OF GINKGO BILOBA IN ELDERLY PATIENTS WITH CONTROLLED ARTERIAL HYPERTENSION AND CIRCULATORY ENCEPHALOPATHY | Abstract similar documents |
| V. V. Jakusevich, N. V. Semenova, I. A. Tihomirova, A. V. Muravyov, S. V. Lychenko | ||
| "... index (by 15,6%, рem0,05/em) and erythrocyte aggregation (degree of aggregation by 45,6%; average aggregate ..." | ||
| Vol 15, No 1 (2019) | Comparison between Bolus Intracoronary versus Bolus Intravenous Injection Regimens of Eptifibatide during Primary Percutaneous Coronary Intervention in Patients with Anterior ST-Segment Elevation Myocardial Infarction | Abstract PDF (Eng) similar documents |
| Mohamed Hassan Nab, Shaimaa Mostafa, Khaled Elrabat, Hamza Kabil, Neama Elmelegy | ||
| "... .062), gender (p=0.488), coronary artery disease risk factors (pem0.05/em), time from onset of pain to admission (p ..." | ||
| Vol 13, No 4 (2017) | COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina | ||
| "... ) variability at night (pem0.05/em) and a morning surge in SBP (p0.01), end systolic volume (pem0.05/em), systolic ..." | ||
| Vol 12, No 4 (2016) | Morphometric changes of the left ventricle and characteristics of peripheral hemodynamics in patients with drug resistant hypertension | Abstract similar documents |
| R. R. Kushkhova, A. G. Avtandilov | ||
| "... .8 g/m vs 102.5±3.4 g/m² in Group 2 (pem0.05/em). The relative left ventricular wall thickness in Group 1 ..." | ||
| Vol 11, No 4 (2015) | EFFECT OF «TREAT-TO-TARGET» ANTIRHEUMATIC THERAPY ON DIASTOLIC DYSFUNCTION OF THE LEFT AND RIGHT VENTRICLES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING 18 MONTHS OF OBSERVATION | Abstract similar documents |
| I. G. Kirillova, D. S. Novikova, T. V. Popkova, Yu. N. Gorbunova, E. I. Markelova, Yu. O. Korsakova, O. A. Fomicheva, A. V. Volkov, E. L. Luchikhina, N. V. Demidova, K. A. Kasumova, S. A. Vladimirov, M. A. Kanonirova, G. L. Lukina, A. A. Novikov, E. N. Aleksandrova, D. E. Karateev, E. L. Nasonov | ||
| "... /MTX + biologics use. Results. After 18 months DDLV incidence decreased by 7% (from 49% to 42%; pem0.05/em ..." | ||
| Vol 15, No 5 (2019) | Outpatient Register of Patients with Acute Myocardial Infarction: Assessment of the Hypertension Impact on Long-term Prognosis | Abstract similar documents |
| D. P. Sichinava, E. P. Kalaydzhyan, N. P. Kutishenko, S. Yu. Martsevich | ||
| "... women and 70 men; in women, AH was recorded more often than in men: 88.9% and 66.0%, respectively, pem0.05/em ..." | ||
| Vol 9, No 2 (2013) | MEDICAL SUPERVISION IN SPECIALIZED CENTER AND THE QUALITY OF LIPID-LOWERING THERAPY IN PATIENTS WITH CARDIOVASCULAR DISEASES (ACCORDING TO THE PROFIL REGISTER) | Abstract similar documents |
| S. Yu. Martsevich, O. V. Gaysenok, S. G. Tripkosh, A. V. Zagrebelnyy, Yu. V. Lukina | ||
| "... in the main group compared to the control (pem0.05/em). Statins were constantly taken by 34% of patients ..." | ||
| Vol 3, No 2 (2007) | NEBIVOLOL IN TREATMENT OF STABLE EXERTIONAL ANGINA PECTORIS | Abstract similar documents |
| Y. V. Gavrilov, V. A. Sulimov, V. I. Makolkin | ||
| "... day results in increase in duration of treadmill test before angina or ST depression (pem0.05/em ..." | ||
| Vol 3, No 5 (2007) | RENAL HEMODYNAMICS AND GLOMERULAR FILTRATION RATE IN MEN AND WOMEN WITH ARTERIAL HYPERTENSION AT THE AGE OF 40-60 YEARS | Abstract similar documents |
| I. G. Fomina, A. E. Bragina, N. E. Gaydamakina, J. N. Salimzhanova | ||
| "... not differ in control group. Positive correlation r=0,61; pem0,05/em) between GGFR and a tobacco smoking ..." | ||
| Vol 4, No 3 (2008) | COMPARATIVE EFFICACY OF ACE INHIBITORS (RAMIPRIL VS ENALAPRIL) IN TREATMENT OF CHRONIC HEART FAILURE IN WOMEN | Abstract similar documents |
| S. N. Tereshchenko, I. V. Zhirov, E. V. Malichenko, E. E. Kazantseva | ||
| "... in ramipril therapy than in enalapril one (р=em0,05/em and рem0,05/em , respectively). Conclusion. Ramipril therapy ..." | ||
| Vol 19, No 1 (2023) | Effect of Antibiotic Therapy on the Sensitivity of Etiological Diagnostic Methods in Patients with Infective Endocarditis after Surgery | Abstract similar documents |
| E. O. Kotova, A. Yu. Moiseeva, Zh. D. Kobalava, E. A. Domonova, A. S. Pisaruk, O. Yu. Silveistrova, P. V. Kakhktsyan, V. V. Vladimirov | ||
| "... hospitalization to a surgical hospital (up 44.2% to 17.3%, pem0.05/em). When comparing microbiological examination ..." | ||
| Vol 13, No 4 (2017) | CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ARTERIAL HYPERTENSION: VASCULAR WALL AS THE TARGET ORGAN IN COMORBID PATIENTS | Abstract similar documents |
| N. A. Karoli, A. P. Rebrov | ||
| "... were associated with smoking status (r=0.61, p0.01), severity of bronchial obstruction (r=-0.49, pem0.05/em ..." | ||
| Vol 10, No 2 (2014) | PRIMARY PREVENTION OF MYOCARDIAL INFARCTION IN MIDDLE-AGED MALES (15-YEAR FOLLOW-UP): CLINICAL AND ECONOMIC ASPECTS OF THE PROBLEM | Abstract PDF (Eng) similar documents |
| A. M. Kalinina, A. V. Kontsevaya | ||
| "... to the second group, fatal MI incidence rate was 42.4% lower, pem0.05/em. Mortality rate in new cases of MI was 35 ..." | ||
| Vol 10, No 5 (2014) | THE RATE AND CHARACTERS OF MASKED ARTERIAL HYPERTENSION AND MASKED INEFFECTIVENESS OF HYPERTENSION TREATMENT IN INDUSTRIAL WORKERS ACCORDING TO THE PREVENTIVE EXAMINATION | Abstract similar documents |
| M. I. Smirnova, E. M. Platonova, A. N. Britov, V. M. Gorbunov, A. D. Deev, Y. N. Koshelyaevskaya | ||
| "... , pem0.05/em), and higher body weight (85.4±13.3 vs. 81.3±10.1 kg, respectively; p=em0.05/em). Treated subjects ..." | ||
| Vol 14, No 6 (2018) | Effectiveness of Chrono-Pharmacotherapy Depending on the Salt Sensitivity of Patients with Arterial Hypertension and Diabetes Mellitus Type 2 | Abstract PDF (Eng) similar documents |
| V. V. Skibitskiy, A. A. Kiselev, A. V. Fendrikova | ||
| "... diastolic BP by 22.1%; pem0.05/em), central aortic pressure (decrease in aortal systolic BP by 15.9%, aortal ..." | ||
| Vol 15, No 1 (2019) | How Does the Presence of Diabetes Affect the Course of Acute Coronary Syndrome in Elderly Patients in Actual Clinical Practice? | Abstract similar documents |
| M. R. Atabegashvili, E. V. Konstantinova, M. D. Muksinova, A. E. Udovichenko, A. P. Nesterov, M. O. Zheltoukhova, L. S. kyzy Muradova, M. Y. Gilarov | ||
| "... (pem0.05/em), age variance was 75-100 years. DM was found in 29% of all elderly patients ..." | ||
| Vol 5, No 4 (2009) | COMORBIDITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A ROLE OF CARDIOVASCULAR DISORDERS | Abstract PDF (Eng) similar documents |
| N. A. Karoli, A. P. Rebrov | ||
| "... hypertension (r=0,21, pem0,05/em), end-diastolic dimension of right ventricle (r=0,24, pem0,05/em) and left ventricle ..." | ||
| Vol 13, No 3 (2017) | ROLE OF PULMONARY HYPERTENSION IN THE DEVELOPMENT OF CIRRHOTIC CARDIOMYOPATHY | Abstract similar documents |
| M. V. Chistyakova, A. V. Govorin, E. V. Radaeva | ||
| "... and blood flow velocity in pulmonary artery (r=0.65, pem0.05/em), between the diameter of the inferior vena cava ..." | ||
| Vol 9, No 1 (2013) | POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| O. V. Sirotkina, A. B. Laskovets, A. S. Lipunova, L. B. Gaykovaya, S. A. Boldueva, T. V. Vavilova | ||
| "... 61.4Ѓ}3.6 to 45.9Ѓ}3.7; pem0.05/em; the induction of 2.5 mM ADP), as well as according to flow ..." | ||
| Vol 9, No 6 (2013) | COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY | Abstract similar documents |
| I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko | ||
| "... increased by 18.2% (pem0.05/em). Group 2: the average CHF class decreased by 29.6% (p0.01), EF increased by 18 ..." | ||
| Vol 10, No 6 (2014) | THE PREVALENCE OF ELEVATED LEVELS OF C-REACTIVE PROTEIN AND ITS ASSOCIATION WITH TRADITIONAL RISK FACTORS AND MORBIDITY AMONG RESIDENTS OF THE RUSSIAN FEDERATION (ACCORDING TO THE ESSE-RF STUDY) | Abstract similar documents |
| S. E. Evstifeeva, S. A. Shalnova, A. D. Deev, T. M. Gatagonova, A. Yu. Efanov, Yu. V. Zhernakova, V. A. Il'in, A. O. Konradi, V. A. Metelskaya, E. V. Oschchepkova, S. V. Romanchuk, O. P. Rotar, I. A. Trubacheva, E. V. Shlyakhto, S. A. Boytsov | ||
| "... of indolent inflammation. Results. HsCRP levels in women was significantly higher compared to males (p0.em005/em ..." | ||
| Vol 1, No 2 (2005) | ANTIHYPERTENSIVE, ORGAN PROTECTIVE, AND METABOLIC EFFICIENCY OF SPIRAPRIL IN PATIENTS WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| M. V. Leonova, M. A. Demidova, A. V. Tarasov, Y. V. Belousov | ||
| "... % of patients, decreased levels of microalbuminuria (pem0,05/em) and β2-microglobulinuria (pem0,05/em), recovered ..." | ||
| Vol 11, No 6 (2015) | The influence of concomitant diseases on a long-term prognosis in patients with chronic ischemic heart disease according to the PROGNOZ IBS register | Abstract similar documents |
| S. N. Tolpygina, S. Yu. Martsevich, A. D. Deev | ||
| "... – by 2.4 times, a history of stroke – by 2.3 times (pem0.05/em); 2 and 3 heart diseases – respectively, by 2 ..." | ||
| Vol 3, No 3 (2007) | THE ASSESSMENT OF EFFECTS OF COMBINED THERAPY WITH MILDRONATE ON LIPID PROFILE, INFLAMMATORY FACTORS AND ENDOTHELIUM FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| I. V. Sergienko, V. V. Kukharchuk, S. A. Gabrusenko, V. V. Malakhov, V. P. Masenko, M. I. Tripoten, T. V. Balahonova | ||
| "... , but LDL-C level significantly reduced (from 3.06±1.32 to 2.7±1.0 mmol/l, pem0.05/em) in IHD patients after 3 ..." | ||
| Vol 8, No 5 (2012) | POSSIBLE PREDICTORS OF ATRIAL FIBRILLATION RECURRENCE IN LONG-TERM PROPHYLACTIC PROPAFENONE THERAPY | Abstract similar documents |
| R. D. Kurbanov, N. U. Zakirov, Sh. K. Azizov, Kh. M. Raubzhanov | ||
| "... more often in women than these in men after 1, 3 and 6 months, respectively , (pem0.05/em). Mean age ..." | ||
| Vol 17, No 2 (2021) | The Efficacy of Thrombolytic Therapy in Inferior Myocardial Infarction with Damage to the Right Ventricular | Abstract similar documents |
| E. S. Mazur, V. V. Mazur, N. S. Kuznetsova, R. M. Rabinovich, K. S. Myasnikov | ||
| "... .7%) patients without RVMI (p0.em005/em). ST-segment decrease by 50% or more in 90 minutes from the TLT was found ..." | ||
| Vol 2, No 2 (2006) | THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL | Abstract similar documents |
| Y. R. Kasherininov, E. K. Shavarova, A. A. Shavarov, N. V. Vachrameeva, A. N. Krutikov, E. V. Smirnova, A. O. Коnrady, E. V. Shlyakhto | ||
| "... ±66 mmol/min/l (pem0.05/em), and it increased from 937±86 to 989±88 mmol/min/l (pem0.05/em) in the atenolol ..." | ||
| Vol 12, No 6 (2016) | State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes | Abstract PDF (Eng) similar documents |
| M. E. Statsenko, M. V. Derevyanchenko | ||
| "... .1% (pem0.05/em for both), respectively. The treatment did not have a negative effect on glucose metabolism ..." | ||
| Vol 12, No 1 (2016) | State of a large vessels and microcirculation - a new target for antihypertensive therapy in patients with hypertension and type 2 diabetes | Abstract similar documents |
| M. E. Statsenko, M. V. Derevyanchenko | ||
| "... .1% (pem0.05/em for both), respectively. The treatment did not have a negative effect on glucose metabolism ..." | ||
| Vol 18, No 1 (2022) | Prognostic Significance of the Integral Index of the Alcohol Situation in Assessing Regional Differences in Mortality from Cardiovascular Diseases in the Russian Federation | Abstract similar documents |
| B. E. Gornyi, A. M. Kalinina, O. M. Drapkina | ||
| "... with a significance level of p em0.05/em. In 2018, intergroup differences in mortality from CSD and IHD were unreliable ..." | ||
| Vol 18, No 2 (2022) | Galectin-3 as a Marker of Cardiorenal Syndrome in Patients with Chronic Heart Failure | Abstract PDF (Eng) similar documents |
| V. I. Podzolkov, N. A. Dragomiretskaya, A. V. Kazadaeva, Yu. G. Belyaev, A. V. Tolmacheva | ||
| "... -3 with increase in NT-proBNP level. Correlation analysis showed significant feedback (r=−0.41, pem0.05/em ..." | ||
| Vol 5, No 1 (2009) | CLINICAL SIGNIFICANCE OF HEART RATE VARIABILITY INDEXES DERIVED FROM 5-MINUTE AND 24-HOUR ECG RECORDINGS IN PATIENTS WITH RHEUMATOID ARTHRITIS | Abstract similar documents |
| D. A. Anichkov, A. A. Platonova | ||
| "... ECG recordings. Results. Patients with RA had lower HRV in comparison with control subjects (pem0,05/em ..." | ||
| Vol 13, No 6 (2017) | ASSESSMENT OF CHANGES IN QUALITY OF PREHOSPITAL TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IN THE LAST FEW YEARS: LIS-1 VS LIS-3 REGISTRIES | Abstract similar documents |
| Yu. V. Semenova, A. V. Zagrebelnyy, N. P. Kutishenko, M. L. Ginzburg, S. Yu. Martsevich | ||
| "... of LIS-1 and LIS-3 registries (pem0.05/em). The quality of prehospital treatment did not differ significantly ..." | ||
| 1 - 100 of 307 Items | 1 2 3 4 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
